Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 4/2024

Edition 3/2024

Edition 2/2024

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn’s disease (ASTIClite): An open-label, multicentre, randomised controlled trial

Lancet Gastroenterol Hepatol. 2024;9(4):333–45

Clinical predictors of early and late endoscopic recurrence following ileocolonic resection in Crohn’s disease

J Crohns Colitis. 2024;18(4):615–27

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn’s disease: 3-year data from the prospective, multicentre PANTS cohort study

Lancet Gastroenterol Hepatol. 2024;9(6):521–38

Inflammatory bowel disease (IBD) patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomised controlled trial in Germany (IBDBIO-ASSIST study)

Aliment Pharmacol Ther. 2024;59(9):1082–95

Early-life diet and risk of inflammatory bowel disease: A pooled study in 2 Scandinavian birth cohorts

Gut. 2024;73(4):590–600

Modified-release phosphatidylcholine (LT-02) for ulcerative colitis: Two double-blind, randomized, placebo-controlled trials

Clin Gastroenterol Hepatol. 2024;22(4):810–20.e7

Maternal and neonatal outcomes in vedolizumab- and ustekinumab-exposed pregnancies: Results from the PIANO registry

Am J Gastroenterol. 2024;119(3):468–76

Histologic remission in inflammatory bowel disease and female fertility: A nationwide study

Gastroenterology. 2024;166(5):802–14.e18

Early initiation of biologics and disease outcomes in adults and children with inflammatory bowel diseases: Results from the epidemiology group of the nationwide Israeli Inflammatory Bowel Disease Research Nucleus cohort

Gastroenterology. 2024;166(5):815–25.e22